Stage I obesity participants had significantly higher levels of plasmatic leptin (p < 0.001) and serum glucose (p = 0.001) and lower levels of plasmatic ghrelin (p < 0.001) with regard to LS and lower levels of plasmatic ghrelin (p < 0.001) with respect to OW participants. The gene discussed is LEP; the disease is obesity disorder.